With the Food and Drug Administration designation in 2017 of 3,4-methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic stress disorder and psilocybin in treatment-resistant depression, psychedelic drugs have continued to garner the attention of researchers and clinicians for their promise of unmatched, rapid improvement in a multitude of psychiatric conditions. Classic psychedelic drugs including psilocybin, lysergic acid diethylamide, and ayahuasca, as well as non-classic drugs such as MDMA and ketamine, are currently being investigated for a potential therapeutic role in trauma, depressive disorders, and other psychopathologies. However, psilocybin and MDMA each have a functional profile well-suited for integration with psychotherapy.
View Article and Find Full Text PDFWith one in five adults in the United States owning a smartwatch or fitness tracker, these devices are poised to impact all aspects of medicine by offering a more objective approach to replace self-reported data. Oncology has proved to be a prototypical example, and wearables offer immediate benefits to patients and oncologists with the ability to track symptoms and health metrics in real time. We aimed to review the recent literature on consumer-grade wearables and its current applications in cancer from the perspective of both the patient and the provider.
View Article and Find Full Text PDFWorld J Psychiatry
April 2021
As the population across the globe continues to dramatically increase, the prevalence of cognitive impairment and dementia will inevitably increase as well, placing increasing burden on families and health care systems. Technological advancements over the past decade provide potential benefit in not only relieving caregiver burden of caring for a loved one with dementia, but also enables individuals with dementia to age in place. Technological devices have served to improve functioning, tracking and mobility.
View Article and Find Full Text PDFWorld J Gastroenterol
March 2021
The field of gastroenterology has recently seen a surge in wearable technology to monitor physical activity, sleep quality, pain, and even gut activity. The past decade has seen the emergence of wearable devices including Fitbit, Apple Watch, AbStats, and ingestible sensors. In this review, we discuss current and future devices designed to measure sweat biomarkers, steps taken, sleep efficiency, gastric electrical activity, stomach pH, and intestinal contents.
View Article and Find Full Text PDFVoice-activated smart speakers, with their ease of setup, low cost, and versatility, could be an affordable and accessible way to improve health and mental health outcomes. In 2018, there were a total of 320 comments generated from verified purchases of a voice-activated smart speaker. These comments revealed there could be potential benefits of reducing loneliness and social isolation for adult users, especially for the older population.
View Article and Find Full Text PDFAust N Z J Psychiatry
September 2020
Background: Research in fall prevention programs has increased in recent years in response to the aging demographics of the United States. To date, limited research and outreach programs have focused on ethnic minorities due to increased cost, language barriers, and cultural differences. Digital media platforms may be a cost-effective avenue to initiate fall prevention programs for minority populations.
View Article and Find Full Text PDFBackground: Dementia is a prevalent disorder among adults and often subjects an individual and his or her family. Social media websites may serve as a platform to raise awareness for dementia and allow researchers to explore health-related data.
Objective: The objective of this study was to utilize Twitter, a social media website, to examine the content and location of tweets containing the keyword "dementia" to better understand the reasons why individuals discuss dementia.
Aust N Z J Psychiatry
September 2018
Geriatr Gerontol Int
May 2017
Aim: One of the major barriers in making a diagnosis and managing dementia in the Chinese American population is the stigma surrounding the disease. The goal of the present study was to examine differences in the stigma and perceptions of dementia and diabetes among Chinese Americans.
Methods: A total of 449 Chinese Americans answered one survey with two self-administered, true/false questionnaires assessing stigma and perceptions toward dementia and diabetes.
Geriatr Gerontol Int
January 2017
Aim: It is known that Chinese Americans associate dementia with stigma and "loss of face." However, further research is required to provide a more complete picture of the extent and nature of stigma in Chinese Americans with family histories of dementia (FHD). The present study examined whether FHD are associated with quantitative measures of stigma in Chinese Americans.
View Article and Find Full Text PDF